$10.880
0.000 (0.00%)收盤時
技術面情緒
綜合共識
技術分析共識
移動平均線共識
Drugs Made In America Acquisition Corp（DMAA）的 MACD 指標為 0.01，顯示 DMAA 為 Strong buy。
Drugs Made In America Acquisition Corp（DMAA）的 20 日簡單移動平均為 10.87，而 Drugs Made In America Acquisition Corp（DMAA）股價為 $—，結果為 Buy。
Drugs Made In America Acquisition Corp（DMAA）的 60 日簡單移動平均為 10.82，而 Drugs Made In America Acquisition Corp（DMAA）股價為 $—，結果為 Buy。
DMAA 技術分析
AI 技術分析 DMAAAs of 2026-11-02, the technical board for Drugs Made In America Acquisition Corp (DMAA) reads strong buy: 8 indicators are flashing buy, 1 are indicating sell, and 4 are neutral. Price at $10.88 sits below the 5-day moving averages and above the 10-day, 20-day, 60-day and 200-day.
Momentum readings: RSI stands at 56.632, MACD stands at 0.0104 (Buy), Stochastic %K stands at 76.389, Stochastic %D stands at 85.339 and CCI stands at 63.414.
DMAA trades above the 60-day SMA (10.82) and above the 200-day SMA (10.64). Immediate resistance sits at Classic R1 10.89, then R2 10.90. Support sits at Classic S1 10.87, then S2 10.86.
Drugs Made In America Acquisition Corp（DMAA）支撐與阻力位
Drugs Made In America Acquisition Corp（DMAA）技術指標
2026-11-03
| 名稱 | 數值 |
|---|---|
| RSI_14 | 56.632 |
| STOCHk_14_3_3 | 76.389 |
| STOCHd_14_3_3 | 85.339 |
| CCI_20 | 63.414 |
| AO_5_34 | 0.018 |
| MOM_10 | 0.015 |
| MACD_12_26_9 | 0.010 |
Drugs Made In America Acquisition Corp（DMAA）的 Relative Strength Index (RSI_14) 為 56.632，形成中性訊號。
Drugs Made In America Acquisition Corp（DMAA）的 Stochastic %K 為 76.389，形成中性訊號。
Drugs Made In America Acquisition Corp（DMAA）的 Stochastic %D 為 85.339，形成 Sell 訊號。
Drugs Made In America Acquisition Corp（DMAA）的 CCI_20 為 63.414，形成中性訊號。
Drugs Made In America Acquisition Corp（DMAA）的 Awesome Oscillator (AO) 為 0.018，形成 Buy 訊號。
Drugs Made In America Acquisition Corp（DMAA）的 Momentum (MOM) 為 0.015，形成 Buy 訊號。
Drugs Made In America Acquisition Corp（DMAA）的 Moving Average Convergence Divergence (MACD) 為 0.010，形成 Buy 訊號。
Drugs Made In America Acquisition Corp（DMAA）移動平均線
2026-11-03
| 週期 | 簡單 | 訊號 |
|---|---|---|
| MA_5 | 10.884 | Sell |
| MA_10 | 10.880 | Buy |
| MA_20 | 10.874 | Buy |
| MA_60 | 10.824 | Buy |
| MA_200 | 10.640 | Buy |
| MA_250 | 10.582 | Buy |
Drugs Made In America Acquisition Corp（DMAA）的 5 日 簡單移動平均為 10.884，而 Drugs Made In America Acquisition Corp（DMAA）股價為 $，結果為 Sell。
Drugs Made In America Acquisition Corp（DMAA）的 10 日 簡單移動平均為 10.880，而 Drugs Made In America Acquisition Corp（DMAA）股價為 $，結果為 Buy。
Drugs Made In America Acquisition Corp（DMAA）的 20 日 簡單移動平均為 10.874，而 Drugs Made In America Acquisition Corp（DMAA）股價為 $，結果為 Buy。
Drugs Made In America Acquisition Corp（DMAA）的 60 日 簡單移動平均為 10.824，而 Drugs Made In America Acquisition Corp（DMAA）股價為 $，結果為 Buy。
Drugs Made In America Acquisition Corp（DMAA）的 200 日 簡單移動平均為 10.640，而 Drugs Made In America Acquisition Corp（DMAA）股價為 $，結果為 Buy。
Drugs Made In America Acquisition Corp（DMAA）的 250 日 簡單移動平均為 10.582，而 Drugs Made In America Acquisition Corp（DMAA）股價為 $，結果為 Buy。
相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。